24 completed, 9 unknown, 6 recruiting, 4 terminated. 12 Phase 2, 10 Not applicable, 9 Phase 3, 4 Phase 1, 4 Phase 4.
Follow Atopic Dermatitis Eczema: new trials by email Literature Review of Atopic Dermatitis Eczema trials Research Report on Atopic Dermatitis Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis IMG-007 - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Enrolling by invitation | Inmagene LLC | 400 | 2026-06-05 | 2026-07-29 |
| Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD Soquelitinib, Placebo - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Recruiting | Corvus Pharmaceuticals, Inc. | 200 | 2026-02-01 | 2026-03-05 |
| A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis IMG-007, Placebo - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Recruiting | Inmagene LLC | 405 | 2025-06-17 | 2026-08-12 |
| Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD. zabalafin - Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema | Phase 2 | Recruiting | Alphyn Biologics | 72 | 2025-03-25 | 2025-08-01 |
| Herbal Ointment in Treating Atopic Dermatitis Topically herbal ointment, Placebo - Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 2 / Phase 3 | Recruiting | En Chu Kong Hospital | 66 | 2025-03-01 | 2025-02-27 |
| Topical ENS-002 for Atopic Dermatitis in Adults ENS-002 - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Terminated | Concerto Biosciences | 9 | 2024-09-18 | 2025-08-14 |
| Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals Nutrient-fortified egg, Regular egg with habitual diet - Atopic Dermatitis Eczema, Aging | Not applicable | Unknown | National University of Singapore | 44 | 2024-07-17 | 2024-07-19 |
| Phase 2 Trial of HY209gel in Atopic Dermatitis Patients HY209GEL Active, Placebo - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Completed | Shaperon | 210 | 2024-03-01 | 2026-06-24 |
| DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Dupilumab - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 216 | 2023-08-14 | 2025-10-08 |
| This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD). ANB032, Placebo - Atopic Dermatitis Eczema | Phase 2 | Terminated | AnaptysBio, Inc. | 201 | 2023-06-13 | 2025-02-14 |
| The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial Lactic acid bacteria NTU 101, Placebo - Atopic Dermatitis, Atopic Dermatitis Eczema | Not applicable | Unknown | SunWay Biotech Co., LTD. | 72 | 2023-04-01 | 2023-03-02 |
| The UPDATE Trial (Uvb Phototherapy in Dermatology for ATopic Eczema) NB-UVB phototherapy, Optimal topical therapy - Atopic Dermatitis Eczema, Atopic Dermatitis | Not applicable | Active not recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 316 | 2023-02-22 | 2026-01-23 |
| Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema Arctiva - Atopic Dermatitis Eczema | Not applicable | Completed | ClinOhio Research Services, LLC | 30 | 2023-02-06 | 2023-06-26 |
| Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Dicloxacillin Oral Capsule, Elocon 0.1 % Topical Cream - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Unknown | Jacob Pontoppidan Thyssen | 45 | 2022-10-24 | 2022-12-21 |
| Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis EVO101 - Atopic Dermatitis Eczema | Phase 2 | Completed | Evommune, Inc. | 119 | 2022-09-27 | 2025-03-05 |
| A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis FRTX-02 Capsule, Placebo - Atopic Dermatitis Eczema | Phase 1 | Terminated | Fresh Tracks Therapeutics, Inc. | 89 | 2022-05-16 | 2023-08-24 |
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Fexofenadine Hydrochloride Topical Lotion 1% (OP2101) - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Completed | OrchestratePharma GmbH | 12 | 2022-04-01 | 2023-03-29 |
| Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children Blue Cap Foam - Atopic Dermatitis, Atopic Dermatitis and Related Conditions | Phase 3 | Completed | Catalysis SL | 58 | 2022-03-15 | 2024-04-15 |
| Metal Panel Allergen Patch Test Study Metal Panel T.R.U.E. Test - Atopic Dermatitis Eczema | Phase 3 | Unknown | Allerderm | 200 | 2022-02-07 | 2023-02-13 |
| Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis Ceradan ® Advanced Cream, Basic cream - Atopic Dermatitis Eczema | Phase 3 | Unknown | KK Women's and Children's Hospital | 60 | 2022-01-10 | 2021-11-29 |
Showing 20 of 47. Sign in to see all of them.
Dermatitis, Atopic (23) · Eczema (15) · Dermatitis (6) · Skin Diseases (4) · Food Hypersensitivity (3) · Psoriasis (3) · Hypersensitivity (2) · Immune System Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Alopecia Areata (1) · Anemia, Sickle Cell (1) · Arthritis, Psoriatic (1) · Asthma (1) · Bipolar Disorder (1) · Breast Neoplasms (1)
Hypersensitivity, Immediate (26) · Skin and Connective Tissue Diseases (26) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (24) · Genetic Diseases, Inborn (24) · Hypersensitivity (24) · Immune System Diseases (24) · Skin Diseases, Eczematous (23) · Skin Diseases (22) · Skin Diseases, Genetic (22) · Dermatitis (18) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Diseases, Papulosquamous (3) · Chronic Disease (2) · Congenital Abnormalities (2)
dupilumab (3) · Blood Specimen Collection (1) · Desonide (1) · Dicloxacillin (1) · EpiCeram (1) · Hand Disinfection (1) · Hand Sanitizers (1) · Mometasone Furoate (1) · Roflumilast (1) · Standard of Care (1) · Therapeutics (1) · crisaborole (1)
Arcutis Biotherapeutics, Inc. (4) · AOBiome LLC (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Inmagene LLC (2) · National Jewish Health (2) · University of California, San Francisco (2) · Ad scientiam (1) · Allerderm (1) · Alphyn Biologics (1) · AnaptysBio, Inc. (1) · Bitop AG (1) · Catalysis SL (1) · ClinOhio Research Services, LLC (1) · Concerto Biosciences (1) · Corvus Pharmaceuticals, Inc. (1)
United States (27) · Canada (11) · United Kingdom (4) · Australia (3) · Netherlands (2) · New Zealand (2) · Bangladesh (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Georgia (1) · Germany (1) · Poland (1)
David Berk, MD (4) · Louise AA Gerbens, MD PhD (2) · Amanda Salisbury, BSN (1) · Andrew McGovern, MD (1) · April W Armstrong, MD, MPH (1) · Bernardo Cervantes, PhD (1) · Claudia Gore, MD PhD (1) · Curt Hamann, M.D. (1) · DirkJan Hijnen, MD PhD (1) · Donald Leung, MD PhD (1) · Eugene Bauer, MD (1) · Gary Pekoe, PhD (1) · Houman Hemmati, MD (1) · Isin Sinem Bagci, MD (1) · Jacob Thyssen, Professor, MD, DMSc (1)
PMID 39292443, PMID 11164708, PMID 14991059, PMID 20642296, PMID 21461244, PMID 23374260, PMID 23800052, PMID 24954372, PMID 25065719, PMID 25922398, PMID 26242300, PMID 26258924, PMID 27148196, PMID 27618652, PMID 27777593, PMID 27861978, PMID 28865094, PMID 28932705, PMID 29117309, PMID 29153780, PMID 29969827, PMID 30119868, PMID 30758843, PMID 30819278, PMID 30899033, PMID 30987008, PMID 31057694, PMID 31626841, PMID 31958431, PMID 32564976, PMID 32708933, PMID 32709423, PMID 32938595, PMID 33176023, PMID 33179341, PMID 33921166, PMID 34132739, PMID 36806068, PMID 37488931, PMID 38431766, PMID 38927748, PMID 39014498, PMID 39980188, PMID 41795905, PMID 42027418, PMID 42340708
2023 (1), R01AR073486 (1), U01AI147462 (1)